欧普康视：关于盐酸毛果芸香碱滴眼液获得药物临床试验批准通知书的公告

Group 1 - The core point of the article is that Opcon Vision has received approval from the National Medical Products Administration for clinical trials of its "Pilocarpine Hydrochloride Eye Drops" [2] Group 2 - The approval allows the company to proceed with clinical trials, indicating progress in its product development pipeline [2]